Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Alemtuzumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
Brief Summary: The goal of this clinical research study is to learn the if the drug combination of alemtuzumab, etoposide and dexamethasone can help to control HLH. The safety of the drug combination will also be studied.